Proteomics

Dataset Information

0

Copper depletion modulates OXPHOS in SOX2/OCT4+ cancer cells to impair triple negative breast cancer metastasis.


ABSTRACT: Copper serves as a co-factor for a host of metalloenzymes that contribute to malignant progression. The orally bioavailable copper chelating agent tetrathiomolybdate (TM) has been associated with a significant survival benefit in high-risk triple negative breast cancer (TNBC) patients. Despite these promising data, the mechanisms by which copper depletion impacts metastasis are poorly understood and this remains a major barrier to advancing TM to a randomized phase II trial. Here, using two independent TNBC models, we report a discrete subpopulation of highly metastatic SOX2/OCT4+ cells within primary tumors that exhibit elevated intracellular copper levels and marked sensitivity to TM. Global proteomic and metabolomic profiling identified TM-mediated inactivation of Complex IV as the primary metabolic defect in the SOX2/OCT4+ cell population. We identified the AMPK/mTORC1 energy sensor as an important downstream pathway and show that AMPK inhibition rescues TM-mediated loss of invasion. Furthermore, loss of the mitochondria-specific copper chaperone, COX17, restricted copper deficiency to mitochondria and phenocopied TM-mediated alterations. These findings identify a novel copper-metabolism-metastasis axis with potential to enrich patient populations in next-generation therapeutic trials.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

TISSUE(S): Lung, Breast

DISEASE(S): Breast Cancer

SUBMITTER: Zhuoning Li  

LAB HEAD: Vivek Mittal

PROVIDER: PXD027089 | Pride | 2021-10-26

REPOSITORIES: Pride

altmetric image

Publications

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis.

Ramchandani Divya D   Berisa Mirela M   Tavarez Diamile A DA   Li Zhuoning Z   Miele Matthew M   Bai Yang Y   Lee Sharrell B SB   Ban Yi Y   Dephoure Noah N   Hendrickson Ronald C RC   Cloonan Suzanne M SM   Gao Dingcheng D   Cross Justin R JR   Vahdat Linda T LT   Mittal Vivek V  

Nature communications 20211215 1


Copper serves as a co-factor for a host of metalloenzymes that contribute to malignant progression. The orally bioavailable copper chelating agent tetrathiomolybdate (TM) has been associated with a significant survival benefit in high-risk triple negative breast cancer (TNBC) patients. Despite these promising data, the mechanisms by which copper depletion impacts metastasis are poorly understood and this remains a major barrier to advancing TM to a randomized phase II trial. Here, using two inde  ...[more]

Similar Datasets

2020-01-21 | PXD015756 | Pride
2016-06-14 | E-GEOD-81849 | biostudies-arrayexpress
2008-11-26 | BIOMD0000000204 | BioModels
2008-11-25 | BIOMD0000000203 | BioModels
2017-06-19 | GSE77515 | GEO
2019-06-18 | GSE103980 | GEO
2019-06-18 | GSE103979 | GEO
2019-06-18 | GSE103978 | GEO
2019-06-18 | GSE119396 | GEO
2017-02-13 | GSE65345 | GEO